In the Press
Vanishing Workforce: An Antimicrobial Resistance Threat
Both public and private sectors should invest in antimicrobial research to attract and retain the best scientists This month, world leaders will gather at the UN General Assembly to address...
Read moreDrug-resistant germs will kill millions more people in coming decades, researchers warn
Since the dawn of the antibiotic age, opportunistic pathogens have evolved defenses faster than humans can develop drugs to combat them. At the same time, humans have unwittingly given the bugs an...
Read moreNew WHO guidance to support manufacturers to reduce AMR risk
The recommendations offered in the guidance is applicable across different areas of manufacturing, from active pharmaceutical ingredients (APIs), through to formulation and packaging. The World Hea...
Read moreWhat Happens When the Last AMR Researcher Turns Off the Lights in the Lab?
Much of modern medicine is possible because of antibiotics. Orthopedic surgeries, caesarean deliveries, and heart and kidney transplants are made safer by antibiotics. Patients who are immunocompromis...
Read moreUK’s NHS to require companies to meet responsible antibiotic manufacturing standard
The United Kingdom's National Health Service (NHS) announced yesterday that pharmaceutical companies applying for a contract through its antibiotic subscription model will have to prove they are meeti...
Read moreAntibiotic innovation is ailing. ‘Brain drain’ may kill it
In today’s labor market, good help is hard to find. For companies developing antibiotics, it’s becoming nearly impossible. Three years ago, I became CEO of the AMR Action Fund, which is investi...
Read more
Belgium Developing New Class of Antibiotics, But Incentives and Market Support Needed
Europe’s pipeline of new antibiotics to tackle the growing antimicrobial resistance (AMR) crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vit...
Read moreAMR Industry Alliance calls for ‘bold, coordinated’ action on antimicrobial resistance
The AMR Industry Alliance this week issued a "call-to-action" in advance of the United Nations (UN) High-Level Meeting on AMR (antimicrobial resistance) in September. The document from the Alliance...
Read moreSite in India Receives Responsible Antibiotic Manufacturing Certification
Pharmaceutical company Viatris announced today that its manufacturing site in India has received Minimized Risk of Antimicrobial Resistance (AMR) certification. The certification, developed by...
Read moreCan We Keep Up With the Resistance?
Antimicrobial resistance (AMR) is a leading cause of death worldwide. In 2019 alone, AMR directly resulted in about 1.27 million deaths, and played a role in almost 5 million deaths. Without intervent...
Read moreAMR Industry Alliance Calls on UN and Member States to Commit to and Advance Bold, Coordinated Action on Antimicrobial Resistance
In the lead-up to the High-level Meeting on AMR, Alliance calls for increased coordination in public and private sectors. Geneva – February 27, 2024 – The AMR Industry Alliance, the largest ind...
Read moreDrug-resistant microbes: ‘brain drain’ is derailing the fight to stop them
A lack of investment is driving researchers who study antimicrobial resistance out of the field, an industry body warns. A lack of funding and incentives for research into antimicrobial resistance...
Read moreViatris Receives receives Global Minimised Risk of Antimicrobial Resistance Certification
The standard was facilitated by BSI for the AMR Industry Alliance, an organization made up of over 100 companies and associations from across the life-sciences industry with the shared goal of providi...
Read moreReport finds brain drain in AMR researchers
The USA-based AMR Industry Alliance conducted a review of publicly available data on the state of antimicrobial resistance (AMR) research and development talent, indicating that researchers are leavin...
Read moreReport warns of ‘brain drain’ from antibiotic research and development
Two new reports this week from a coalition of industries working to combat antimicrobial resistance (AMR) highlight some of the progress that's been made, along with a critical problem that could unde...
Read moreAMR Industry Alliance Finds Exodus of Scientific Talent Threatens Progress Toward Antimicrobial Global Health Threat
Despite its growing death toll, scientific ‘brain drain’ compounds efforts to tackle antimicrobial resistance. Geneva – February 8, 2024 – New analysis published today has identified an exodu...
Read more2023 AMR Industry Alliance Progress Report: A Call to Action Against Antimicrobial Resistance
Geneva – February 5, 2024 – The AMR Industry Alliance, one of the largest private sector coalitions dedicated to combatting antimicrobial resistance (AMR), today announced the publication of its 2...
Read moreWhy the UN High-Level Meeting is critical to the fight against AMR
Next year, the United Nations will hold a High-Level Meeting (HLM) to discuss the global coordination necessary to tackle antimicrobial resistance (AMR). The rise of AMR continues to be one of...
Read more
AMR Industry Alliance and Toilet Board Coalition Launch Toolkit: “The Sanitation Fight Against AMR”
Toolkit intended to empower local sanitation businesses in the fight against antimicrobial resistance. Geneva, Switzerland – 7 September 2023 – The AMR Industry Alliance, together with The Toil...
Read morePressure Mounts On Pharma To Act On Environmental Targets
There are growing demands from government officials, investors and employees for the pharmaceutical industry to reduce emissions and waste, and – most of all – make environmental sustainability a...
Read more
Tech-Powered War on AMR
The following article first ran in BioSpectrum Asia on July 4, 2023 The consistent increase in antimicrobial resistance (AMR) is threatening to undo many of the gains of modern medicine. The situat...
Read more
New Pricing Policies Needed To Curb AMR Impact, States Industry Alliance Report
Medicines For Europe Echoes Report Recommendations 22 February 2023 Executive Summary The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the...
Read more
The Free Market is Failing Us on Antibiotics
This article first appeared in Marketplace on 22 December 2022. Researchers at Harvard Medical School in 2016 recorded a now-famous demonstration with E. coli bacteria — a species often behind...
Read more
Antimicrobial Resistance: The Silent Pandemic
Antimicrobial Resistance: The Silent Pandemic was produced by Citi GPS: Global Perspectives and Solutions in December 2022...
Read more
The Global Pharmaceutical Industry Must Play a Key Role in AMR Mitigation
Antibiotics are essential medicines that have revolutionized modern healthcare, but the rise of antimicrobial resistance (AMR) is threatening their effectiveness. Antibiotics have delivered a major im...
Read more
The Role of the Environment in the Fight Against AMR
This article originally appeared in The Guardian on November 10, 2022 Much of the global coordination on combatting AMR has rightly been focused on incentives, appropriate use, stewardshi...
Read more
How India Can Nip the Looming Threat of Antimicrobial Resistance in the Bud
This article was originally published in Economic Times on September 11, 2022. Synopsis The National Action Plan on AMR and the Andhra Pradesh's State Action Plan have also called for stringent li...
Read more
Tackling the Silent Pandemic: AMR Industry Alliance Sets the Standard
This piece first appeared in European Pharmaceutical Review on 17 August 2022. Here AMR Industry Alliance representatives Melissa Gong Mitchell and Steve Brooks discuss how the Alliance is mobili...
Read more
Research Calls for Regulators to Accelerate the Approval of Antibiotics
Report by One Health Trust says acknowledging antimicrobial resistance in regulatory frameworks for accelerated drug approval could improve access to new antibiotic...
Read more
Drugmakers Aim to Curb Release of Antibiotic Waste Into the Environment
A coalition of drugmakers is introducing new standards aimed at curbing the release of antibiotic waste into the environment amid growing concerns over drug resistance that’s been linked t...
Read more
Antibiotic Drugmakers Take Steps to Self-Impose Environmental Safeguards
LONDON, June 14 (Reuters) - In the absence of global standards limiting toxic emissions produced by antibiotics at the point of manufacture, the pharmaceutical industry has come up with its own standa...
Read more
Health Europa Quarterly Issue 21 Explores AMR
Health Europa Quarterly has published its twenty-first issue which features AMR, as well as the AMR Industry Alliance's Progress Report, acknowledging "the urgent need to facilitate a sustainable mark...
Read more
AMR Progress Report in Health Europa Quarterly
AMR Industry Alliance and its Progress Report have been featured in Health Europa Quarterly: Progress being made on AMR, but marketplace reforms needed "AMR Industry Alliance discusses...
Read more
Companies must responsibly manufacture the antimicrobials society needs
This article was first published in STAT on 30 January 2020 by Steve Brooks and Alba Tiley In a world challenged by microbes resistant to antibiotics, many medical interventions that rely on the...
Read more
Manufacturers of new antibiotics go bankrupt
700,000 people die from drug-resistant infections – so why do antibiotic companies face bankruptcy? This article was first published in the NZZamSonntag on 26 January 2020 by Birgit Voigt The...
Read more
The Fight Against Superbugs: Properly Incentivising Antimicrobial R&D Is Key
This article was published in Pharma Boardroom on 16 January 2020. Opinion by Greg Frank. Drug-resistant superbugs are evolving at a rapid pace. In fact, it is estimated that 700,000 people die fr...
Read more
Opinion: How to oppose the menace of antimicrobial resistance
This article was published in Devex 20 January 2020. Opinion by Serufusa Sekidde. Despite its magnitude, lack of access to antibiotics is a largely overlooked public health issue. 5.7 million peop...
Read more
Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance
This article was published in Health Policy Watch 16 January 2020 by Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful n...
Read more
Industry urges more government action on antibiotic development
This article was published in CIDRAP 16 January 2020. A report by Chris Dall. The level of funding for late-stage research and development of new antibiotics and other products to combat antimicro...
Read more
Industry calls on governments to invest more in antibiotics research
This article was published in Science Business 16 January 2020 by Florin Zubașcu. Alarm over the rise of antimicrobial resistance has prompted an increase in early stage research and led to the di...
Read more
Antibiotics: Responsibly Making the Drugs Society Needs
This article was published in Pharma Boardroom on 13 November 2019. Opinion by Steve Brooks, Advisor to the AMR Industry Alliance. Steve Brooks outlines the threat that antimicrobial resistance (A...
Read more
Pharmaceuticals in the Environment
This article was published on PharmTech on 2 August, 2018 (Pharmaceutical Technology, Volume 42, Issue 8). Content by Sean Milmo. "An Antimicrobial Resistance (AMR) Industry Allian...
Read more
Antimicrobial resistance and vaccines – Life science industry makes the link and drives progress
This Q&A was first published on PharmExec on 20 April, 2018. Interview by Julian Upton. 1. When trying to reduce antimicrobial resistance, how can vaccines help? Vaccines are critical and po...
Read more
NZZ – We need a sustainable business model
This interview was first published on NZZ on 24 February 2018. Interview by Birgit Voigt. NZZ on Sunday: Why is the pharmaceutical industry not developing more new antibiotics? Thomas Cueni: Today...
Read more
CGTN – Augmentation de la résistance antimicrobienne dans le monde
Garance Upham (Vice-President of World Against Antibiotic Resistance - WAAAR), Marc Sprenger Director WHO secretariat for antimicrobial resistance), Thomas Cueni (Chair of AMR Industry Alliance) expla...
Read more
Antimicrobial Resistance The “Scariest” Public Health Issue, Needs Financial R&D Incentives, Industry Says
On the eve of the annual January World Health Organization Executive Board meeting, an alliance of pharmaceutical industries launched its first report on efforts made to curb antimicrobial resistance....
Read more
Report tracks industry progress on drug resistance
A report today from an international association of life sciences companies suggests that the private sector is making progress in meeting its commitment to help solve the antimicrobial resistance (AM...
Read more
Funding outlook shifts in fight against antimicrobial resistance
LONDON — Twenty-two research-based biopharmaceutical companies — including AstraZenica, GlaxoSmithKline and Merck — invested more than $2 billion in research and development to counter an...
Read more
3 Questions with Thomas Cueni, Director General IFPMA, Chair, AMR Industry Alliance
Next week is crunch time for the Global Fund to Fight Aids, TB and Malaria. The agency, which channels donor money into lower-income, higher-burden countries for the world’s three big killer infecti...
Read more
Inside Germany’s push for a global anti-microbial resistance hub
BERLIN — Germany is positioning itself as a key player in antimicrobial resistance research with the expected launch of a Research and Development Collaboration Hub, likely to be housed in Berlin. G...
Read more
Report highlights progress made in global AMR fight
A new report from the United Nations Foundation and the Wellcome Trust is highlighting the progress that's been made, and the work that needs to be done, in the year since world leaders made a commitm...
Read more
WHO issues alarming report on coming shortage of antibiotics
A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO...
Read more
The Earth Security Report 2017
The Earth Security Report 2017 provides a roadmap for global business to align their growth to the demands for social inclusion and environmental security that are defining the countries in which they...
Read more
Fighting superbugs cannot be a luxury for the rich
While the world has woken up to the threat of antimicrobial resistance and is starting to respond, many low-income countries are struggling to find capacity and need greater support. That is the headl...
Read more
In a press release published last week, the IFPMA announced the establishment of the Antimicrobial Resistance (AMR) Industry Alliance
The announcement was made by IFPMA’s Director-General Tomas Cueni, during the B20 Health Conference in Berlin. The Alliance’s role is to bring together stakeholders from the industry in order to h...
Read more
New drug industry alliance will tackle antibiotic resistance
Industry leaders from the drug industry have come together to tackle the growing threat of drug-resistant infection, which experts warn could cause the deaths of 10 million people each year by 2050....
Read more
AMR Industry Alliance formed to ensure pharma involvement in addressing antimicrobial resistance
CIDRAP News: Pharma leaders announce alliance to fight antimicrobial resistance “An international association of pharmaceutical, biotechnology, and diagnostics companies announced the formation o...
Read more
Pharma leaders announce alliance to fight antimicrobial resistance
An international association of pharmaceutical, biotechnology, and diagnostics companies today announced the formation of a new alliance to monitor and drive industry efforts to fight antimicrobial re...
Read more
Neues Bündnis gegen Antibiotikaresistenz
Gegen das anhaltende Problem der Antibiotikaresistenz hat sich jetzt ein Bündnis geschlossen. Die 'AMR Industry Alliance' vereint Pharmaunternehmen, Generikahersteller, Biotech- und Diagnostikfirmen...
Read more
New Industry Alliance aimed at antimicrobial resistance
Pharmaceutical industry representatives today announced a new alliance to fight antimicrobial resistance. The announcement came during a meeting of the private sector of the most advanced countries....
Read more
Charity urges drug industry to consider supplier role in “superbug” spread
Drug manufacturers, retail pharmacies and regulators have a role to play in curbing antimicrobial resistance say campaigners urging industry to ensure their API suppliers are not part of the problem....
Read more